Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Cardiac ablation has emerged as a transformative medical procedure for patients struggling with irregular heart rhythms particularly atrial fibrillation AFib By targeting and eliminating problematic a ...

Hospital length of stay, hospital costs, and opioid use were reduced among patients who underwent cryoablation during ...

Unlike conventional radiofrequency ablation and cryoablation for atrial fibrillation, PFA relies on microsecond-scale, high-voltage electrical fields to induce cardiac cell death to isolate the ...

MASON, Ohio, January 13, 2025--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation ... the cryoSPHERE MAX™ cryoablation probe.

Cryoablation helps restore normal heart rhythm by targeting the cells responsible for the rapid heartbeats (atrial fibrillation). A thin, flexible tube (cryoballoon) is inserted to identify the ...

Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will ...

which are more susceptible to injury during RF or cryoablation. Together, these technological and procedural advancements in PFA contribute to its growing acceptance as a viable alternative for atrial ...